Development of Integrin Targeting Chimeras (ITACs) for the Lysosomal Degradation of Extracellular Proteins
ChemMedChem · 2024-12-16 · 19 (24)
DOI: 10.1002/cmdc.202300643 ↗At a glance
Journal article in ChemMedChem, published online on 2024-10-29. Written by Yaxian Zhou and 3 co-authors. Institution: Lachman Institute of Pharmaceutical Development, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, 53705, USA. Major MEDLINE topics: Lysosomes, Integrins. Cited 24 times so far (Crossref); 25 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NIGMS NIH HHS, University of Wisconsin - Madison Office of the Vice Chancellor for Research and Graduate Education, Wisconsin Alumni Research Foundation.
Abstract (original language)
The emerging of lysosomal targeting chimera (LYTAC) expands the field of targeted protein degradation (TPD) to include the extracellular proteins for precise depletion. However, most of the reported LYTACs either induce ubiquitous degradation of the protein of interest (POI) in a broad range of tissues or specifically target liver cells. More tissue‐selective degraders are highly desirable. Herein, we describe the development of cyclic RGD (cRGD) peptide‐antibody conjugates as a novel class of integrin targeting chimeras (ITACs) with potential cancer selectivity. Our results indicate that the ITACs are able to recruit integrin to induce the degradation of both soluble and membrane targets in the lysosome. We observed higher efficiency of ITACs on degrading membrane protein in cancer cells, providing a promising platform for cancer‐selective TPD strategy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Lachman Institute of Pharmaceutical Development, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, 53705, USA.
- Department of Chemistry, University of Wisconsin-Madison, Madison, WI, 53706, USA.
ORCID profiles: Weiping Tang
Funding
- NIGMS NIH HHS
- University of Wisconsin - Madison Office of the Vice Chancellor for Research and Graduate Education
- Wisconsin Alumni Research Foundation
- NIH HHS
- National Institutes of Health
Cite
APA
Zhou, Y., Liao, Y., Zhao, Y., & Tang, W. (2024). Development of Integrin Targeting Chimeras (ITACs) for the Lysosomal Degradation of Extracellular Proteins. ChemMedChem, 19(24). https://doi.org/10.1002/cmdc.202300643
Vancouver
Zhou Y, Liao Y, Zhao Y, Tang W. Development of Integrin Targeting Chimeras (ITACs) for the Lysosomal Degradation of Extracellular Proteins. ChemMedChem. 2024;19(24). doi:10.1002/cmdc.202300643
BibTeX
@article{Zhou2024,
author = {Zhou, Yaxian and Liao, Yaxian and Zhao, Yuan and Tang, Weiping},
title = {Development of Integrin Targeting Chimeras (ITACs) for the Lysosomal Degradation of Extracellular Proteins},
journal = {ChemMedChem},
year = {2024},
volume = {19},
number = {24},
doi = {10.1002/cmdc.202300643}
}
EUVIMED